{"title":"成人植入式经静脉心脏复律除颤器","authors":"Destiny R Brady, C. Macleod","doi":"10.1097/01.CCN.0000529944.38466.AB","DOIUrl":null,"url":null,"abstract":"Ms. K, 59, has a history of type 2 diabetes, depression, heart failure (HF) with reduced ejection fraction (HFrEF), and renal insufficiency. Three months ago, she experienced a myocardial infarction (MI) that led to HF. Ms. K’s ejection fraction during her last hospitalization was 30%, and she is New York Heart Association (NYHA) functional class III. She was admitted for placement of an implantable cardioverter-defibrillator (ICD).","PeriodicalId":19344,"journal":{"name":"Nursing Critical Care","volume":"13 1","pages":"34–38"},"PeriodicalIF":0.0000,"publicationDate":"2018-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1097/01.CCN.0000529944.38466.AB","citationCount":"4","resultStr":"{\"title\":\"Implantable transvenous cardioverter-defibrillators in adults\",\"authors\":\"Destiny R Brady, C. Macleod\",\"doi\":\"10.1097/01.CCN.0000529944.38466.AB\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Ms. K, 59, has a history of type 2 diabetes, depression, heart failure (HF) with reduced ejection fraction (HFrEF), and renal insufficiency. Three months ago, she experienced a myocardial infarction (MI) that led to HF. Ms. K’s ejection fraction during her last hospitalization was 30%, and she is New York Heart Association (NYHA) functional class III. She was admitted for placement of an implantable cardioverter-defibrillator (ICD).\",\"PeriodicalId\":19344,\"journal\":{\"name\":\"Nursing Critical Care\",\"volume\":\"13 1\",\"pages\":\"34–38\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2018-05-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.1097/01.CCN.0000529944.38466.AB\",\"citationCount\":\"4\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Nursing Critical Care\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1097/01.CCN.0000529944.38466.AB\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"Nursing\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Nursing Critical Care","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1097/01.CCN.0000529944.38466.AB","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Nursing","Score":null,"Total":0}
Implantable transvenous cardioverter-defibrillators in adults
Ms. K, 59, has a history of type 2 diabetes, depression, heart failure (HF) with reduced ejection fraction (HFrEF), and renal insufficiency. Three months ago, she experienced a myocardial infarction (MI) that led to HF. Ms. K’s ejection fraction during her last hospitalization was 30%, and she is New York Heart Association (NYHA) functional class III. She was admitted for placement of an implantable cardioverter-defibrillator (ICD).
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
